13 completed, 3 terminated, 3 withdrawn, 2 active not recruiting. 23 Phase 2, 5 Phase 3, 1 Phase 1.
Follow Lorazepam: new trials by email Literature Review of Lorazepam trials Research Report on Lorazepam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prescribing Lorazepam for IUD Insertion: Pilot Feasibility Study Lorazepam 1 mg, Ibuprofen 800 mg - Pain, IUD | Phase 2 | Withdrawn | University of Wisconsin, Madison | 2025-10-01 | 2025-10-30 | |
| Acute Agitation in Emergency Psychiatry Sublingual Dexmedetomidine, Buccal midazolam, Oral lorazepam - Agitation | Phase 2 / Phase 3 | Recruiting | Lone Baandrup | 132 | 2024-12-30 | 2025-01-01 |
| Therapies for Down Syndrome Regression Disorder Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib - Down Syndrome, Regression | Phase 2 | Completed | University of Colorado, Denver | 66 | 2023-06-29 | 2026-09-03 |
| Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose IXT-m200, Lorazepam, Haloperidol - Methamphetamine Intoxication (Disorder) | Phase 2 | Terminated | InterveXion Therapeutics, LLC | 20 | 2021-06-30 | 2023-11-18 |
| Lorazepam for the Analgosedation of Pediatric Patients in Mechanical Ventilation. Lorazepam 4 mg/ml - Analgesia | Phase 2 | Unknown | Bambino Gesù Hospital and Research Institute | 9 | 2020-12-01 | 2020-11-27 |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care Haloperidol, Lorazepam, Placebo - Delirium, Locally Advanced Malignant Neoplasm | Phase 2 / Phase 3 | Active not recruiting | M.D. Anderson Cancer Center | 110 | 2019-07-17 | 2026-06-15 |
| Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care Placebos, Lorazepam - Acute Pain | Phase 2 | Terminated | Maria Pacella | 1 | 2019-01-25 | 2020-03-09 |
| Effect of A Single Dose of Lorazepam on Salivary Cortisol Response in Children Undergoing Digestive Endoscopy: Lorazepam, Placebo - Anxiety | Phase 2 | Completed | St. Justine's Hospital | 98 | 2017-06-28 | 2018-09-05 |
| A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting Brivaracetam, Lorazepam - Epilepsy | Phase 2 | Completed | UCB Biopharma S.P.R.L. | 46 | 2017-02-06 | 2020-12-16 |
| PF-06372865 in Subjects With Photosensitive Epilepsy PF-06372865, Placebo, Lorazepam - Reflex Epilepsy, Photosensitive | Phase 2 | Completed | Pfizer | 7 | 2015-12-16 | 2018-03-14 |
| Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer Lorazepam, Placebo, Haloperidol decanoate - Advanced Cancers | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 93 | 2014-01-01 | 2026-07-17 |
| Sunitinib or Cediranib for Alveolar Soft Part Sarcoma Cediranib, Sunitinib, Prochlorperazine - Sarcoma, Alveolar Soft Part | Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2011-07-18 | 2026-02-02 |
| Glutamatergic Modulation of Cocaine-related Deficits Ketamine 0.41 mg/kg, Ketamine 0.71 mg/kg, Lorazepam 2 mg - Cocaine Dependence | Phase 2 | Completed | New York State Psychiatric Institute | 8 | 2011-02-01 | 2019-04-30 |
| Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325 AZD7325, Lorazepam, Placebo - Anxiety Disorders | Phase 2 | Completed | AstraZeneca | 369 | 2008-12-01 | 2010-10-08 |
| Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) lorazepam or diazepam - Status Epilepticus | Phase 2 / Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 259 | 2008-02-01 | 2012-12-18 |
| Seizure Therapy With Intravenous Levetiracetam and Lorazepam Levetiracetam 1 g IV + Lorazepam 2 mg IV, Placebo + Lorazepam 3 mg IV - Seizures | Phase 2 / Phase 3 | Withdrawn | Massachusetts General Hospital | 2008-01-01 | 2012-11-01 | |
| Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy Decadron®, Benadryl®, Ativan® - Nausea, Vomiting | Phase 2 | Terminated | University of South Florida | 7 | 2007-10-01 | 2014-07-25 |
| Effects of Pentazocine Versus Lorazepam on Manic Symptoms Pentazocine, Lorazepam - Bipolar Disorder, Schizoaffective Disorder | Phase 2 | Completed | Mclean Hospital | 19 | 2007-01-01 | 2019-03-06 |
| Lorazepam Sedation for Critically Ill Children Lorazepam, Midazolam, Lorazepam CI - Critical Illness | Phase 2 / Phase 3 | Completed | The Emmes Company, LLC | 179 | 2004-09-01 | 2023-03-20 |
| MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status Dexmedetomidine, Lorazepam - Delirium | Phase 2 | Completed | Vanderbilt University | 100 | 2004-08-01 | 2018-09-11 |
Showing 20 of 23. Sign in to see all of them.
Delirium (3) · Anxiety Disorders (2) · Acute Pain (1) · Agnosia (1) · Alcoholism (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bipolar Disorder (1) · Catatonia (1) · Cocaine-Related Disorders (1) · Cognitive Dysfunction (1) · Critical Illness (1) · Down Syndrome (1) · Epilepsy (1) · Epilepsy, Reflex (1)
M.D. Anderson Cancer Center (2) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2) · AstraZeneca (1) · Bambino Gesù Hospital and Research Institute (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · InterveXion Therapeutics, LLC (1) · Lone Baandrup (1) · Maria Pacella (1) · Massachusetts General Hospital (1) · Mclean Hospital (1) · National Cancer Institute (NCI) (1) · New York State Psychiatric Institute (1) · Pfizer (1) · St. Justine's Hospital (1) · The Emmes Company, LLC (1)
United States (19) · Canada (2) · Brazil (1) · Denmark (1) · Puerto Rico (1)
Alice P Chen, M.D. (1) · Beth L Murphy, MD/PhD (1) · Carl Hart, PhD (1) · Carrie Randall, PhD (1) · David Hui (1) · David Hui, MD (1) · E Wesley Ely, MD, MPH (1) · Elias Dakwar, MD (1) · Elise Sannar, MD (1) · Haydar Frangoul, MD (1) · James Chamberlain, MD (1) · Jeffrey L Blumer, MD, PhD (1) · Jensena Carlson, MD (1) · Joaquin Espinosa, PhD (1)
PMID 18073360, PMID 20233428, PMID 24035344, PMID 24756515, PMID 27993298, PMID 28975307, PMID 29363356, PMID 30877186, PMID 31418168, PMID 36302173, PMID 40742738
2019 (1), 2023 (1), K23DA014291 (1), R21CA186000 (1), U01DA053043 (1), U10CA081920 (1)